Clinical Trial

Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection

Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter, ambispective cohort study evaluates the safety and efficacy of trans-arterial Indocyanine Green (ICG) fluorescence-guided laparoscopic liver watershed resection for Hepatocellular Carcinoma (HCC). The study aims to compare the outcomes of the trans-arterial ICG staining approach versus the conventional trans-portal (portal vein) ICG staining approach.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-07.
Trial Details
NCT Number NCT07295275
Lead Sponsor West China Hospital
Conditions Liver Cancer
Enrollment 200 participants
Start Date 2026-03-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-03